Dissanaike Sharmila 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Dissanaike Sharmila
Director
Transactions
- Award
Common Stock
2025-01-30+17,950→ 87,180 total - Award
Stock Option (Right to Buy)
2025-01-30$1.73/sh+35,900$62,107→ 35,900 totalExercise: $1.73Exp: 2035-01-30→ Common Stock (35,900 underlying)
Footnotes (2)
- [F1]The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.